BMS-564,929
id:
bms-564-929-192-5591231
title:
BMS-564,929
text:
BMS-564,929 is an investigational selective androgen receptor modulator (SARM) which is being developed by Bristol-Myers Squibb for treatment of the symptoms of age-related decline in androgen levels in men ("andropause"). These symptoms may include depression, loss of muscle mass and strength, reduction in libido and osteoporosis. Treatment with exogenous testosterone is effective in counteracting these symptoms but is associated with a range of side effects, the most serious of which is enlarg
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/BMS-564,929
date created:
date modified:
2024-01-07T22:16:13Z
main entity:
{"identifier":"Q4836003","url":"https://www.wikidata.org/entity/Q4836003"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/c0/BMS-564%2C929.svg","width":516,"height":247}
fields total:
13
integrity:
15